Breath analysis combined with cardiopulmonary exercise testing and echocardiography for monitoring heart failure patients: the AEOLUS protocol.


Journal

Journal of breath research
ISSN: 1752-7163
Titre abrégé: J Breath Res
Pays: England
ID NLM: 101463871

Informations de publication

Date de publication:
09 08 2023
Historique:
received: 22 03 2023
accepted: 31 07 2023
medline: 10 8 2023
pubmed: 1 8 2023
entrez: 31 7 2023
Statut: epublish

Résumé

This paper describes the AEOLUS pilot study which combines breath analysis with cardiopulmonary exercise testing (CPET) and an echocardiographic examination for monitoring heart failure (HF) patients. Ten consecutive patients with a prior clinical diagnosis of HF with reduced left ventricular ejection fraction were prospectively enrolled together with 15 control patients with cardiovascular risk factors, including hypertension, type II diabetes or chronic ischemic heart disease. Breath samples were collected at rest and during CPET coupled with exercise stress echocardiography (CPET-ESE) protocol by means of needle trap micro-extraction and were analyzed through gas-chromatography coupled with mass spectrometry. The protocol also involved using of a selected ion flow tube mass spectrometer for a breath-by-breath isoprene and acetone analysis during exercise. At rest, HF patients showed increased breath levels of acetone and pentane, which are related to altered oxidation of fatty acids and oxidative stress, respectively. A significant positive correlation was observed between acetone and the gold standard biomarker NT-proBNP in plasma (

Identifiants

pubmed: 37524075
doi: 10.1088/1752-7163/acec08
doi:

Substances chimiques

isoprene 0A62964IBU
Acetone 1364PS73AF

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Creative Commons Attribution license.

Auteurs

Denise Biagini (D)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Nicola R Pugliese (NR)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Federico M Vivaldi (FM)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Silvia Ghimenti (S)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Alessio Lenzi (A)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Francesca De Angelis (F)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Matyas Ripszam (M)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Tobias Bruderer (T)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Silvia Armenia (S)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Federica Cappeli (F)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Stefano Taddei (S)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Stefano Masi (S)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Fabio Di Francesco (FD)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Tommaso Lomonaco (T)

Department of Chemistry and Industrial Chemistry, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH